Progyny Inc (PGNY) Stock
Key stats
- Market cap
- $2.69B
- Price / Earnings ratio
- 29.5x
- EPS (TTM)
- $1.14
- Volume
- Loading
- 52-week high
- $36.45
- 52-week low
- $16.10
Source: third-party data provider, as of November 13, 2026
Compare with PGNY
Recent news

PGNY or CRL: Which Is the Better Value Stock Right Now?
PGNY or CRL: Which Is the Better Value Stock Right Now?
PGNY

PGNY vs. CRL: Which Stock Is the Better Value Option?
PGNY vs. CRL: Which Stock Is the Better Value Option?
PGNY

Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know
PGNY

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns
Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns
PGNY
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 83.21
- MACD 12/26/9
- 2.23
- EMA 9 of MACD
- 1.39
- MACD histogram
- 0.84
- SMA 50
- $28.08
- Price above SMA 50
- EMA 50
- $29.10
- Price above EMA 50
- SMA 200
- $24.70
- Price above SMA 200
- EMA 200
- $25.79
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.21 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

PGNY or CRL: Which Is the Better Value Stock Right Now?
PGNY or CRL: Which Is the Better Value Stock Right Now?
PGNY

PGNY vs. CRL: Which Stock Is the Better Value Option?
PGNY vs. CRL: Which Stock Is the Better Value Option?
PGNY

Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know
PGNY

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns
Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns
PGNY

Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
PGNY

Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks
PGNY

Why Progyny Stock Plunged, Then Gradually Recovered Today
Why Progyny Stock Plunged, Then Gradually Recovered Today
PGNY

Progyny Q2 Earnings Call Highlights
Progyny Q2 Earnings Call Highlights
PGNY

Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say
Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say
PGNY

Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates
PGNY
News tone: automated (AI) classification of the article's content, not a price prediction.
About Progyny Inc
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter Anevski CPA | CEO & Director | 1967 |
| Mr. David J. Schlanger J.D. | Executive Chairman | 1959 |
| Mr. Mark S. Livingston CPA | Chief Financial Officer | 1966 |
| Ms. Melissa B. Cummings | Chief Operating Officer | 1970 |
| Ms. Allison Swartz | Executive VP, General Counsel & Secretary | 1990 |
| Mr. Geoffrey Clapp | Chief Product Officer | 1974 |
| Mr. Steven Leist | Chief Technology Officer | — |
| Mr. James Hart | Vice President of Investor Relations | — |
| Ms. Risa Fisher | Chief Marketing Officer | — |
| Ms. Cassandra Pratt | Chief Human Resources Officer | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 83.21
- MACD 12/26/9
- 2.23
- EMA 9 of MACD
- 1.39
- MACD histogram
- 0.84
- SMA 50
- $28.08
- Price above SMA 50
- EMA 50
- $29.10
- Price above EMA 50
- SMA 200
- $24.70
- Price above SMA 200
- EMA 200
- $25.79
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $35.00
- Average
- $36.67
- High
- $38.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -18.7 | +5.2 | ||||||||||
| 2022 | -21.1 | -3.2 | +19.2 | -26.0 | -19.8 | -1.8 | +3.7 | +29.9 | -5.0 | +17.4 | -16.5 | -15.3 |
| 2023 | +12.4 | +6.7 | -16.0 | +5.0 | +10.9 | +3.9 | +8.3 | -9.8 | -9.0 | -9.0 | +12.9 | +7.5 |
| 2024 | +2.4 | -5.8 | +5.9 | -12.2 | -16.5 | +2.7 | -0.6 | -13.3 | -29.0 | -7.0 | +3.8 | +10.6 |
| 2025 | +30.7 | -4.5 | +1.5 | -1.1 | -5.7 | +1.4 | +6.6 | +5.2 | -8.1 | -11.8 | +43.1 | +1.6 |
| 2026 | -7.3 | -26.9 | -3.5 | +10.2 | +37.4 | +10.0 | +5.7 | -18.8 | -1.8 | +17.5 | +24.1 |



